Title |
Financing of U.S. Biomedical Research and New Drug Approvals across Therapeutic Areas
|
---|---|
Published in |
PLOS ONE, September 2009
|
DOI | 10.1371/journal.pone.0007015 |
Pubmed ID | |
Authors |
E. Ray Dorsey, Joel P. Thompson, Melisa Carrasco, Jason de Roulet, Philip Vitticore, Sean Nicholson, S. Claiborne Johnston, Robert G. Holloway, Hamilton Moses |
Abstract |
We estimated U.S. biomedical research funding across therapeutic areas, determined the association with disease burden, and evaluated new drug approvals that resulted from this investment. |
Mendeley readers
The data shown below were compiled from readership statistics for 74 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 5 | 7% |
United Kingdom | 1 | 1% |
Unknown | 68 | 92% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 18 | 24% |
Student > Ph. D. Student | 14 | 19% |
Student > Bachelor | 9 | 12% |
Other | 7 | 9% |
Student > Master | 6 | 8% |
Other | 13 | 18% |
Unknown | 7 | 9% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 21 | 28% |
Agricultural and Biological Sciences | 13 | 18% |
Social Sciences | 6 | 8% |
Psychology | 5 | 7% |
Engineering | 4 | 5% |
Other | 16 | 22% |
Unknown | 9 | 12% |